baber/WOPTO huggingface dataset:
Patent EP-3596736-A1 (EP)
Inventor: LAHODA EDWARD J
IPC: G21C3/04
Filed: 2018-02-19
Abstract: A method of forming a water resistant boundary on a fissile material for use in a water cooled nuclear reactor is described. The method comprises coating the fissile material, such as a pellet of U3Si2 and/or the grain boundaries, to a desired thickness with a suitable coating material, such as atomic layer deposition or a thermal spray process. The coating material may be any non-reactive material with a solubility at least as low as that of UO2. Exemplary coating materials include ZrSiO 4 , FeCrAl, Cr, Zr, Al-Cr, CrAl, ZrO 2 , CeO 2 , TiO 2 , SiO 2 , UO 2 , ZrB 2 , Na 2 O-B 2 O 3 -SiO 2 -Al 2 O 3  glass, Al 2 O 3 , Cr 2 O 3 , carbon, and SiC, and combinations thereof. The water resistant layer may be overlayed with a burnable absorber layer, such as ZrB 2  or B 2 O 3 -SiO 2  glass.
Patent EP-3597617-A1 (EP)
Inventor: TANAKA SATORU
IPC: C04B35/30
Filed: 2018-03-15
Abstract: A sintered Ni ferrite body having a composition comprising, calculated as oxide, 47.0-48.3% by mol of Fe 2 O 3 , 14.5% or more and less than 25% by mol of ZnO, 8.2-10.0% by mol of CuO, and more than 0.6% and 2.5% or less by mol of CoO, the balance being NiO and inevitable impurities, and having an average crystal grain size of more than 2.5 µm and less than 5.5 µm.
Patent EP-3684904-A1 (EP)
Inventor: LEUPOLD MARCO
IPC: C12M1/00
Filed: 2018-09-06
Abstract: The invention relates to a container (1, 1b), in particular a container (1, 1b) of a bioreactor (1a, 1b), having a container interior (22) designed for being filled with a medium (8) including a photoreactive material, and designed for at least partially triggering at least one photochemical reaction, in particular a photosynthesis of the photoreactive material, comprising at least one illuminant receiving pouch (11) which is at least partially transparent for an electromagnetic radiation (14), and which is arranged on a illuminant opening (12) at least partially within the container interior (22) and is designed to at least partially receive at least one illuminant (15, 15a, 15b, 15c, 15d, 15e) from an outer side (A) through the illuminant opening (12, 12a, 12b), wherein the illuminant (15, 15a, 15b, 15c, 15d, 15e) is designed to at least partially irradiate the medium (8) such that the photochemical reaction of the photoreactive material can be triggered by an electromagnetic radiation (14) emitted by the illuminant (15, 15a, 15b, 15c, 15d, 15e) and the illuminant (15, 15a, 15b, 15c, 15d, 15e) is isolated in relation to the medium (8) by the illuminant receiving pouch (11).
Patent EP-3420299-A1 (EP)
Inventor: TINICHIGIU TAL
IPC: F41G1/00
Filed: 2018-03-27
Abstract: L'invention concerne un procédé de calcul d'instructions d'étalonnage de visée d'arme à feu par traitement d'une image d'une cible de tir. Le procédé consiste à recevoir au moins une image à partir d'au moins un dispositif d'imagerie, la ou les images représentant une cible de tir avec un groupe de tir comprenant une pluralité de trous de balle, à recevoir une indication d'un type d'arme à feu et/ou d'un type de visée d'arme à feu pour l'étalonnage, à utiliser l'au moins un processeur matériel pour calculer des instructions d'étalonnage de visée d'arme à feu selon au moins un emplacement relatif de l'un de la pluralité de trous de balle par rapport à un autre trou de la pluralité de trous de balle par traitement de la ou des images et d'au moins un paramètre prédéfini de l'arme à feu et/ou du type de visée d'arme à feu, et à délivrer en sortie des instructions de présentation pour présenter les instructions d'étalonnage de visée d'arme à feu sur un dispositif d'affichage d'un dispositif client.
Patent EP-3475167-A1 (EP)
Title: Système de siège à agencement décalé
Inventor: WILLIAMSON JOHN
IPC: B64D11/06
Filed: 2018-03-26
Abstract: La présente invention concerne un ensemble siège pour un aéronef de passagers. L'ensemble siège comprend une pluralité de sièges passagers comprenant un premier siège passager et un second siège passager. Chacun des sièges passagers comprend un fond articulé pour permettre de déplacer le siège passager entre une première position verticale et une seconde position inclinée. De plus, le second siège passager peut être positionné dans une configuration décalée par rapport au premier siège passager. Une coque de confidentialité externe fixe entoure partiellement chaque siège et comprend au moins une paroi arrière et une base fixée au plancher de l'aéronef de passagers pour recevoir chacun des sièges passagers. De plus, une console centrale peut également être située à l'intérieur de chacune des coques de confidentialité externes fixes et située de manière adjacente à chacun des sièges passagers.
Patent EP-3684566-A1 (EP)
Inventor: DE NATRIS ALBERTUS
IPC: B26D5/00
Filed: 2018-09-20
Abstract: The invention relates to an adjusting device for adjusting the gap width between a punch and counter pressure cylinder of a rotary punch device, comprising an eccentric by means of which the position of a running ring of the counter-pressure cylinder can be adjusted relative to the counter pressure cylinder, and a servomotor which is designed to adjust the gap width between the punch and counter press cylinder. A control device for controlling the servomotor in which an adjusting curve taking into account the eccentricity of the eccentric, is provided. The invention also relates to an associated rotary punch device and to a method for receiving an adjusting curve of an adjusting device and to a method for adjusting a gap width between a punch cylinder and a counter pressure cylinder of a rotary punch machine comprising an adjusting device with an eccentric.
Patent EP-3612200-A1 (EP)
Inventor: VARMA YUG
IPC: C12N7/00
Filed: 2018-04-20
Abstract: L'invention concerne, entre autres, des compositions, des systèmes et des méthodes destinés à prévenir ou à traiter l'acné. L'invention concerne des compositions, des combinaisons, des systèmes et des méthodes comprenant au moins un bactériophage de Propionibacterium acnes, au moins un composé anti-acné et un support pharmaceutiquement acceptable. L'invention concerne également des compositions, des combinaisons et des systèmes comprenant un bactériophage de Propionibacterium acnes et une enzyme. L'invention concerne également des méthodes de prévention ou de traitement de l'acné.
Patent EP-3864761-A1 (EP)
Inventor: WIGARD JEROEN
IPC: H04B7/06
Filed: 2018-10-10
Abstract: According to an example aspect of the present invention, there is provided a method comprising, receiving, by a user equipment from a wireless access network node, an indication on beam measurement reporting mode,receiving a plurality of reference signals, performing measurements on the received reference signals at different reception beams in accordance with the received indication on beam measurement reporting mode, and transmitting to the network node a measurement report comprising quality indicators of measured reference signals in accordance with the received indication on beam measurement reporting mode. The measurement of the reference signals is adapted on the basis of the received indication on beam measurement reporting mode, comprising selecting between at least two of an interference measurement mode, a handover measurement mode, and an interference and handover measurement mode.
Patent EP-3619195-A1 (EP)
Inventor: SATHE DHANANJAY G
IPC: C07C317/28
Filed: 2018-04-27
Abstract: L'invention concerne une alternative et un procédé amélioré pour la préparation d'aprémilast (formule I) et de la forme B d'aprémilast ou d'un sel pharmaceutiquement acceptable correspondant. Le nouveau procédé comprend l'hydrogénation dans l'acétone, la cyclisation et l'acétylation suivies par la condensation dans la méthylisobutylcétone (MIBK) et le mélange d'acide acétique dans des rapports volumiques spécifiques.
Patent EP-3697382-A1 (EP)
Title: Compositions and methods to enhance ultrasound-mediated delivery of pharmaceutical agents
Inventor: LANGER ROBERT S
IPC: A61K47/26
Filed: 2018-10-16
Abstract: Disclosed herein are compositions comprising a pharmaceutical agent and an ultrasound enhancing agent. The compositions are useful in combination with ultrasound to enhance delivery of a pharmaceutical agent to, for example, tissue of a subject in need thereof. Accordingly, also provided herein are methods involving ultrasound for delivering a pharmaceutical agent to a subject, e.g., a subject that has inflammatory bowel disease or proctitis.
Patent EP-3625355-A1 (EP)
Inventor: KEOGH MICHAEL-CHRISTOPHER
IPC: G01N33/573
Filed: 2018-05-18
Abstract: L'invention concerne des analyses pour une activité de remodelage du nucléosome à l'aide de mononucléosomes recombinants fonctionnalisés. Les mononucléosomes recombinants fonctionnalisés comprennent un octamère d'histone comprenant des protéines d'histone H2A, H2B, H3 et H4 recombinantes et un modèle d'ADN comprenant une séquence de positionnement de nucléosome qui positionne efficacement l'octamère d'histone et un site de signal. L'invention concerne en outre des procédés d'utilisation de l'analyse pour quantifier l'activité enzymatique d'enzymes de remodelage et identifier des modulateurs de l'activité enzymatique de remodelage.
Patent EP-3559130-A1 (EP)
Inventor: WALDO ROSALYN
IPC: C08K3/36
Filed: 2018-05-14
Abstract: There is provided a floor coating composition used for coating of a floor, which has improved performance and durability without a boundary between the cured and uncured areas. Also provided is a floor coating composition for flooring material, which contains components (A) to (E) below as essential components: component (A): a bifunctional (meth)acrylate compound not having an alicyclic structure; component (B1): a trifunctional or more urethane (meth)acrylate oligomer; component (B2): a hexafunctional or more urethane (meth)acrylate oligomer other than the component (B1); component (C): a melamine (meth)acrylate; component (D): metal oxide nanoparticles; and component (E): an active energy ray polymerization initiator. The amount of component (A) contained is more than 24 weight% and less than 50 weight%, the amount of component (B1) contained is more than 10 weight% and less than 35 weight%, and the amount of component (C) contained is not less than 10 weight% and less than 20 weight%, and component (E) contains a hydrogen abstraction photopolymerization initiator.
Patent EP-3629737-A1 (EP)
Inventor: CHAKRABORTY DEBOLEENA
IPC: C07D401/04
Filed: 2018-05-24
Abstract: This application relates to efficient and economical synthetic chemical processes for the preparation of pesticidal thioethers. Specifically, the present application relates to improved reactive crystallization methods for producing compounds useful in the preparation of pesticidal thioethers.
Patent EP-3630325-A1 (EP)
Title: Method of treating traumatic brain injury
Inventor: CHAN PHILLIP
IPC: B01D15/00
Filed: 2018-05-21
Abstract: The present invention concerns methods of treating a patient suffering from a traumatic brain injury (TBI), comprising contacting said patient's blood with a sorbent for an inflammatory mediator and kits for performing such treatments.
Patent EP-3634824-A1 (EP)
Inventor: BJÖRKMAN MATHIAS
IPC: B60W20/10
Filed: 2018-06-01
Abstract: The present invention relates to a method for propelling a vehicle (100) comprising a first power source (101) being an internal combustion engine and a second power source (110) comprising at least one electrical machine. The vehicle (100) is configured to be selectively driven according to a first mode (M1) and a second mode (M2), wherein in said second mode (M2) providing power for propelling said vehicle (100) is prioritized more in relation to fuel efficiency of said vehicle (100) than in said first mode (M1). When a maximum power for propelling said vehicle (100) is requested, power delivered by said first power source (101) and said second power source (110) is controlled such that the total power delivered by said first (101) and said second (110) power source exceeds the maximum deliverable power of said first power source (101). The total power delivered by said first (101) and said second (110) power source is allowed to exceed the maximum deliverable power of said first power source (101) when said vehicle is being driven according to said second mode (M2).
Patent EP-3703810-A1 (EP)
Inventor: KOYA VIJAY
IPC: A61N1/36
Filed: 2018-11-02
Abstract: A system may include a controller operably connected to a diabetic therapy delivery system. The controller may be configured to: receive therapy inputs including a therapy input indicative of a glucose measure; determine a therapy input index using the at least one therapy input including the therapy input indicative of a glucose measure; map the determined therapy input index to a graded glucose control; and set the graded glucose control based on the mapped graded glucose control for the determined therapy input index, wherein the graded glucose control includes at least one of a neuromodulation target, a neuromodulation type, or at least one neuromodulation parameter value. The diabetic therapy delivery system may be configured to deliver the therapy for graded glucose control using the graded glucose control that was set based on the mapped graded glucose control.
Patent EP-3602298-A1 (EP)
Inventor: CHENG LIQUN
IPC: G06F9/50
Filed: 2018-11-20
Abstract: Methods, systems, and computer storage medium storing instructions for obtaining data splitting a plurality of general-purpose processing units in a processing system into a high-priority domain and a low-priority domain, wherein the general-purpose processing units in the high-priority domain are assigned to perform one or more tasks comprising one or more high-priority tasks, and the general-purpose processing units in the low-priority domain are assigned to perform one or more low-priority tasks; and during runtime of the processing system, obtaining memory usage measurements that characterize usage of system memory by the high-priority domain and the low-priority domain; and adjusting, based on the memory usage measurements, a configuration of (i) the high-priority domain, (ii) the low-priority domain, or (iii) both to adjust utilization of the system memory by the general-purpose processing units.
Patent EP-3639724-A1 (EP)
Inventor: KUBO MASAHIRO
IPC: G02B23/26
Filed: 2018-06-06
Abstract: There are provided a processor device that can allow a change in the tone of an image not to be noticeable with less wasteful processing, a method of operating the processor device, an endoscope system, an image display device that can display an image in which a change in a tone is not noticeable, a method of operating the image display device, and an operating program for the image display device. 
     A processor device (12) includes: an image acquisition unit (90) that acquires a static image of an object to be observed; an embedding unit (93) that embeds a correction profile, which is created by a creation unit (92) according to tone change-related information about a change in the tone of the static image, in the static image; and an output unit (94) that outputs the static image, in which the correction profile is embedded, to the outside. In an image display device (37), a static image in which a correction profile is embedded is received and correction is performed on the static image by using the correction profile. Then, the static image on which the subjected has been performed is displayed on a display (38).
Patent EP-3723904-A1 (EP)
Title: Fluidic card assembly
Inventor: JACKSON STUART
IPC: B01L3/00
Filed: 2018-12-07
Abstract: A fluidic card assembly (1) comprises an inlet (20) for introducing a fluid to the fluidic card assembly (1), a turbulent flow portion (30) downstream of the inlet (20), the turbulent flow portion (30) comprising a widening fluid channel (31) whereby a fluid introduced via the inlet (20) channel undergoes turbulence, and a laminar flow portion (40) downstream of the turbulent flow portion (30). The laminar flow portion (40) is configured to allow fluid passing from the turbulent flow portion (30) into the laminar flow portion (40) to establish a laminar flow pattern, and is configured to house a biochip (44) such that a fluid in the laminar flow portion (40) may be in contact with the biochip (44).
Patent EP-3641806-A1 (EP)
Inventor: KIM DONGKYOON
IPC: A61K48/00
Filed: 2018-06-22
Abstract: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof. Specifically, the invention provides isolated anti-HIV antibodies that are capable of neutralizing at least 95% of the HIV pseudoviruses listed in Table 1 and neutralizing 100% of the HIV clade B, G and D viruses listed in Table 1 with an IC50 value of less than 50 ug/mL. Further provides are the sequences especially complementarity-determining region (CDR) sequences of antibodies disclosed.
Patent EP-3723805-A1 (EP)
Title: Treatment of psychiatric conditions such as resistant depression, bipolar disorder and/or major depressive disorder via application of repetitive transcranial magnetic stimulation with thyroid hormone treatment and/or quetiapine
Inventor: ZAMAR ANDY
IPC: A61P25/18
Filed: 2018-12-14
Abstract: The present invention relates to treatment of a psychiatric condition, for example resistant depression (RD), bipolar disorder (either threshold or sub-threshold) and/or major depressive disorder via application of repetitive transcranial magnetic stimulation with a drug treatment, in particular application of repetitive transcranial magnetic stimulation with treatment to modulate the activity of the neurones and induce neuroplasticity and the use of Thyroid hormone treatment to increase quantity or activity of thyroid hormones, for example for treatment of thyroid dysfunction. Patients may be selected for treatment by testing for the presence of normal thyroid function.
Patent EP-3647875-A1 (EP)
Inventor: WAKABAYASHI YUKI
IPC: C08L67/00
Filed: 2018-06-22
Abstract: The present invention relates to a binder resin composition capable of giving a toner remarkably excellent in fusing property on polypropylene films, and to a toner for developing electrostatic images that contains the binder resin composition, [1] A binder resin composition for toners, containing an amorphous polyester resin which has a polyester resin-derived constituent moiety that is a constituent moiety derived from a polyester resin and a modified polypropylene polymer A-derived constituent moiety that is a constituent moiety derived from a modified polypropylene polymer A having a carboxylic acid group or a carboxylic anhydride group and in which the polyester resin-derived constituent moiety and the modified polypropylene polymer A-derived constituent moiety bond to each other via a covalent bond, wherein the polymer A is a polypropylene polymer terminally-modified with an unsaturated bond-having carboxylic acid compound or an anhydride thereof, and in the polyester resin, the amount of the polymer A-derived constituent unit is 8 parts by mass or more and 30 parts by mass or less relative to 100 parts by mass of the total of the alcohol component and the carboxylic acid component constituting the polyester resin-derived constituent moiety; and [2] a toner for developing electrostatic images, containing the binder resin composition of [1].
Patent EP-3649646-A1 (EP)
Title: A subject-specific system and method for prevention of body adaptation for chronic treatment of disease
Inventor: ILAN YARON
IPC: G16C10/00
Filed: 2018-07-01
Abstract: There are provided herein a system and a computer implemented method for preventing, mitigating or treating partial/complete loss of effect of one or more drugs or medical devices administered to or used by a subject in need thereof due to adaptation, tolerance, and/or tachyphylaxis, and/or for preventing, mitigating or treating non-responsiveness to one or more drugs, maximizing therapeutic effect of one or more drugs, or for improving target or non-target organ/organs response to therapy, the system/method include (processing circuit configured to): receiving a plurality of physiological or pathological parameters of the subject; applying a machine learning algorithm on the plurality of physiological or pathological parameters; and determining a subject-specific administration regimen of a drug or a medical treatment, wherein the administration regimen comprises drug administration parameters, cell/tissue/organ stimulation parameters, adjuvant parameters or any combination thereof; wherein the administration regimen is irregular.
Patent EP-3648823-A1 (EP)
Title: Acoustic measurement systems and methods
Inventor: CHAMTIE HAYAT
IPC: A61M16/06
Filed: 2018-07-03
Abstract: A respiratory therapy (RT) system including one or more acoustic generators (8500) to produce an inaudible acoustic signal. The acoustic generator(s), such as when coupled to a patient interface or air circuit of a respiratory therapy device, may provide inaudible acoustic signals indicative of one or more parameters, such as a flow rate or a pressure of the flow of air, or a type of or useable life of a component (e.g. patient interface). The system may have an acoustic receiver that may detect one or more acoustic signals from the acoustic generator, the RT system, the patient or the environment.
Patent EP-3724591-A1 (EP)
Inventor: VASSEUR JULIEN
IPC: F22B37/00
Filed: 2018-12-13
Abstract: The invention relates to a method for evaluating fouling in the passages of a spacer plate (10) of a tubular heat exchanger (11) in which first, second and third pressure sensors (31, 32, 33) are arranged, the method comprising the following steps: (a) during a temporary operation phase of the heat exchanger, determining a value, as a function of the wide range level (NGL) time, on the basis of measurements taken by the first and third pressure sensors (31, 33), and determining a value, as a function of the narrow range level (NGE) time, on the basis of measurements taken by the second and third pressure sensors (31, 33); (b) determining a value, as a function of the steam range level deviation time, ΔNGV, corresponding to the NGL from which a component representing a variation in the free water surface in the heat exchanger has been filtered out, on the basis of the NGL and NGE values; (c) comparing the thus determined ΔNGV value with a set of reference profiles ΔNGV i  for this temporary operation phase of the heat exchanger, each reference profile ΔNGV i  being associated with a fouling level, so as to identify a target reference profile ΔNGV opt  among the ΔNGV i  reference profiles for the temporary operating phase of the heat exchanger which is the closest to the determined ΔNGV value; (d) rendering on an interface (3) the fouling level associated with the identified target reference profile ΔNGV opt .
Patent EP-3659946-A1 (EP)
Title: Container floor assembly
Inventor: ZHANG LIZHOU
IPC: B65D90/00
Filed: 2018-08-29
Abstract: A container floor assembly includes a floor unit (1), a blocking member (2) and a limiting member (3), wherein the blocking member (2) is supported on the floor unit (1), and the limiting member (3) detachably connects the floor unit (1) and the blocking member (2) in a manner of restricting a relative lateral movement of the blocking member (2) and the floor unit (3).
Patent EP-3678846-A1 (EP)
Inventor: LINDSEY JAMES M
IPC: B29K105/00
Filed: 2018-09-07
Abstract: Methods for preparing oriented polymer tubes, such as biodegradable polymer tubes suitable for in vivo use, are provided herein. The disclosed methods provide alternatives to the typical extrusion/expansion methods by which oriented polymeric tubes for such uses are commonly produced. Advantageously, the disclosed methods can provide more homogeneous molecular orientation of crystallizable polymers within the tube walls, which can endow such polymeric tubes with enhanced strength (e.g., resistance to compression) and toughness.